Covid Vaccine – Talk Bio

Moderna’s COVID Vaccine Wins FDA Approval for At-Risk Young Children

2 weeks ago talkbio0Tagged Approved, At-Risk, Child, conditions, Covid Vaccine, Moderna, Spikevax, United States Food and Drug Administration

Moderna; FDA approval; COVID vaccine; children; at-risk; Spikevax; underlying conditions; full approval

HHS lifts stop work order on Vaxart’s COVID-19 trial, continues funding for the 10,000-participant study

3 months ago talkbio0Tagged BARDA, Covid Vaccine, COVID19 (disease), Lifting, next-generation, oral pill vaccine, Phase 2b Trial, stop work, Vaccines, Vaxart

Vaxart, COVID-19 vaccine, oral pill vaccine, stop work order lifted, BARDA funding, 10, 000-participant study, Phase 2b trial, next-generation COVID vaccine

Sanofi Invests $500M in Novavax’s Covid Vaccine, Exploring Commercialization and Flu Combination

1 year ago talkbio0Tagged Combined, commercialization, Covid Vaccine, Investments, Novavax, sanofi

Sanofi, Novavax, Covid vaccine, commercialization, flu combination, $500M investment